Ripple kopen? Dit zijn de mogelijkheden

Ipsen Aandeel

113,10EUR -0,40EUR -0,35%
<
Bedrijf
Kalender
Profiel
>
<
Gerelateerd
Obligaties
>

Ipsen - Profiel

Ipsen SA manufactures pharmaceutical products for oncology, neuroscience and rare diseases. It operates through following segments: Specialty Care and Consumer Healthcare. The Specialty Care segment focuses on Oncology with Somatuline, a somatostatin analog for the treatment of neuroendocrine tumors; Cabometyx, the single-agent treatment with significant improvement across all key efficacy endpoints in second-line renal cell carcinoma; Onivyde, a differentiated product with overall survival benefit addressing a high unmet medical need in pancreatic cancer; and Decapeptyl, an established and growing product in Europe and China for prostate cancer and Rare Diseases with Nutropin, a liquid formulation of recombinant human growth hormone and Increlex, a recombinant insulin-like growth factor of human origin. The Consumer Healthcare segment include brands such as Smecta, a naturally extracted purified clay for the symptomatic treatment of acute diarrhea; Tanakan, a standardized extract from the leaves of Ginkgo biloba for the treatment of various neurological and neuro-sens or ial disorders; Forlax, an osmotic laxative indicated for the symptomatic treatment of constipation in adults and children; and Fortrans, a colon cleansing solution indicated for patients in preparation for endoscopic, radiological examinations or colonic surgery. The company was founded by Henri Beaufour in 1929 and is headquartered in Boulogne-Billancourt, France.

Aandeelhouder

Eigenaar in %
Beaufour Family56,40
Freefloat42,26
Oddo BHF Asset Management SAS2,47
Norges Bank Investment Management1,28
The Vanguard Group, Inc.1,14
BNP Paribas Asset Management France SAS1,09
Amundi Asset Management SA (Investment Management)0,91
Ipsen SA0,89
BFT Investment Managers SA0,75
Ostrum Asset Management SA0,69
BlackRock Fund Advisors0,64
La Banque Postale Asset Management SA0,49
CPR Asset Management SA0,40
Janus Capital Management LLC0,32
Lyxor International Asset Management SAS0,30

Adres

65, quai Georges Gorse, 92650 Boulogne-Billancourt
Postbus:
Telefoon: 33158335000
Fax: 33158335001
Internet: http://www.ipsen.com

Management

Ivana Magovcevic-Liebisch, PhD
Chief Business Officer & Executive Vice President
David D. Meek
Chief Executive Officer & Director
Aymeric Le Chatelier
Chief Financial Officer & Executive Vice President
Regis Mulot
Chief Human Resources Officer & Executive VP
Sotirios G. Stergiopoulos, MD
Chief Medical Officer & Senior Vice President
Alexandre P. LeBeaut, MD
Chief Scientific Officer
Paul Jai Sekhri
Director
Henri Beaufour
Director
Anne Beaufour
Director
Carol Xueref
Director
Philippe Bonhomme
Director
Christophe Vérot
Director
Benoit Hennion, MBA
Executive VP & President-Consumer Healthcare
François Garnier
Executive Vice President & General Counsel
Dominique Bery, MBA
Executive Vice President-Strategy & Transformation
Aidan Murphy, PhD
Executive Vice President-Technical Operations
Margaret A. Liu MD, PhD
Independent Director
Pierre Martinet
Independent Director
Michèle Ollier, MD
Independent Director
Hervé Couffin
Independent Director
Piet Wigerinck, PhD
Independent Director
Hélène Auriol-Potier EMBA
Independent Director
Carol Stuckley, MBA
Independent Director
Marc M. P. de Garidel EMBA
Non-Executive Chairman
Didier Véron
SVP-Public Affairs & Corporate Communications
Olivier Jochem
Secretary
Dominique Laymand
Senior VP, Chief Ethics & Compliance Officer
Antoine Flochel
Vice Chairman
Ian Weatherhead
Vice President-Corporate External Communications
Heather White
Vice President-Global Internal Audit
Eugenia Litz
Vice President-Investor Relations

Invoer toevoegen